TNF and neoplasm: This may be because intratumoral DC injection enhances the anti-tumor immune response induced by subcutaneous injection of DC by pro-immunomodulating cytokines in the TME, reducing Treg cells, and directly inhibiting tumor proliferation by TNF (170, 171).